Stock Taper 
BELLEVUE ASSET MANAGEMENT AG
Latest 13F filing data - Q4 2015
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
| MA Masimo Corporation | MASI | 75K | $3.11M |
 Incyte Corporation | INCY | 79K | $8.57M |
 Ligand Pharmaceuticals Incorporated | LGND | 81.64K | $8.85M |
 MacroGenics, Inc. | MGNX | 83K | $2.57M |
 Biogen Inc. | BIIB | 84.03K | $25.74M |
 Globus Medical, Inc. | GMED | 87.7K | $2.44M |
 Illumina, Inc. | ILMN | 91.42K | $17.55M |
 Zimmer Biomet Holdings, Inc. | ZBH | 95.5K | $9.8M |
 CVS Health Corp. | CVS | 96.2K | $9.4M |
 AngioDynamics, Inc. | ANGO | 100K | $1.21M |
 Becton, Dickinson and Company | BDX | 105.08K | $16.19M |
 Centene Corp. | CNC | 105.63K | $6.95M |
 Baxter International Inc. | BAX | 110K | $4.2M |
 Pfizer Inc. | PFE | 110K | $3.55M |
 UnitedHealth Group Incorporated | UNH | 120K | $14.12M |
 Amgen Inc. | AMGN | 123K | $19.97M |
 Arbutus Biopharma Corp | ABUS | 125K | $556K |
 Ionis Pharmaceuticals, Inc. | IONS | 138K | $8.55M |
 Stryker Corporation | SYK | 140.7K | $13.08M |
 Exelixis, Inc. | EXEL | 170K | $959K |